153044
3-Aminopyrazole-4-carbonitrile
97%
Synonym(s):
3-Amino-4-cyanopyrazole
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Empirical Formula (Hill Notation):
C4H4N4
CAS Number:
Molecular Weight:
108.10
Beilstein:
2647
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Recommended Products
Assay
97%
mp
172-174 °C (lit.)
functional group
nitrile
SMILES string
Nc1n[nH]cc1C#N
InChI
1S/C4H4N4/c5-1-3-2-7-8-4(3)6/h2H,(H3,6,7,8)
InChI key
FFNKBQRKZRMYCL-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
3-amino-4-cyanopyrazole was used to study the impurities in zaleplon bulk drug.
Building block used in the synthesis of a variety of heterocycles.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Synlett, 65-65 (2006)
Ch Bharathi et al.
Journal of pharmaceutical and biomedical analysis, 44(1), 101-109 (2007-03-21)
Zaleplon is a pyrazolopyrimidine derivative and possesses sedative and hypnotic properties. Seven unknown impurities in zaleplon bulk drug at levels below 0.1% were detected by reverse-phase high performance liquid chromatography (HPLC). The starting material, 3-amino-4-cyanopyrazole and an intermediate, N-[3-[3-(dimethylamino)-1-oxo-2-propenyl]-phenyl]-N-ethylacetamide (DOPEA)
Helvetica Chimica Acta, 89, 30-30 (2006)
Alessandro Antonelli et al.
Molecular and cellular endocrinology, 393(1-2), 56-64 (2014-06-17)
CLM29 (a pyrazolo[3,4-d]pyrimidine, that inhibits RET, epidermal growth factor receptor, vascular endothelial growth factor receptor, and has an anti-angiogenic activity) has anti-neoplastic activity in papillary dedifferentiated thyroid cancer. Here we tested CLM29 in medullary thyroid cancer (MTC), in primary MTC
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service